EPO: Clinical Trials

11 trials of EPO, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 11 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 311Completed 7, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Unknown 1

Follow EPO: new trials by email Literature Review of EPO trials Research Report on EPO

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.
Erythropoietin + Probiotic, EPO - Anaemia, Chronic Kidney Disease
Phase 3CompletedBadr University802026-02-012026-10-30
Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT
decitabine, umbilical cord blood, Granulocyte-colony stimulating factor - Poor Graft Function
Phase 3Not yet recruitingThe First Affiliated Hospital of Soochow University1002023-08-012023-06-09
Decitabine for Poor Graft Function Post Allo-HSCT
Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist - Poor Graft Function
Phase 3CompletedThe First Affiliated Hospital of Soochow University762023-07-012026-10-23
Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma
recombinant human erythropoietin - Lymphoma, Anemia
Phase 3UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine1302021-04-012021-08-11
Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)
Epo, Control - Extreme Prematurity
Phase 3CompletedUniversity of Washington9412013-12-012026-05-19
Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period
Ferric carboxymaltose, Erythropoietin, Placebo - Hip Fractures
Phase 3CompletedFundación Pública Andaluza para la gestión de la Investigación en Sevilla3032010-06-012015-07-28
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Bone Marrow Biopsy, Epoetin Alfa, Laboratory Biomarker Analysis - Anemia, Chronic Myelomonocytic Leukemia
Phase 3Active not recruitingNational Cancer Institute (NCI)2472009-04-202026-11-13
REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial
erythropoietin - Kidney Failure, Chronic, Drug Resistance
Phase 3TerminatedQueen's University62006-10-012009-02-12
Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis
Venofer and stable erythropoietin (EPO) regimen, stable erythropoietin (EPO) regimen - Anemia
Phase 3CompletedAmerican Regent, Inc.1212002-07-012021-05-19
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
External Beam Radiation Therapy, Cisplatin, Internal Radiation Therapy - Anemia, Cervical Adenocarcinoma
Phase 3CompletedGynecologic Oncology Group1142001-08-012017-08-09
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Erythropoietin, Filgrastim, Transfusion - Anemia, Myelodysplastic Syndromes
Phase 3CompletedEastern Cooperative Oncology Group1181998-03-042023-06-29

Conditions studied

Anemia (6)  ·  Myelodysplastic Syndromes (2)  ·  Anemia, Refractory (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Hip Fractures (1)  ·  Kidney Failure, Chronic (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Lymphoma (1)  ·  Premature Birth (1)  ·  Radiation Injuries (1)  ·  Renal Insufficiency, Chronic (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

The First Affiliated Hospital of Soochow University (2)  ·  American Regent, Inc. (1)  ·  Badr University (1)  ·  Eastern Cooperative Oncology Group (1)  ·  Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)  ·  Gynecologic Oncology Group (1)  ·  National Cancer Institute (NCI) (1)  ·  Queen's University (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  University of Washington (1)

Countries

United States (4)  ·  China (2)  ·  Canada (1)  ·  Egypt (1)  ·  Spain (1)

Top investigators

Amit K Verma (1)  ·  Gillian Thomas (1)  ·  Karen E Yeates, MD, FRCP(C), MPH (1)  ·  Kenneth B. Miller, MD (1)  ·  Mark A Falone, MD (1)  ·  Sandra E Juul, MD, PhD (1)  ·  Yue Han (1)  ·  Yue Han, Professor (1)

Results publications

PMID 16818281, PMID 19564636, PMID 22353604, PMID 26181032, PMID 27057344, PMID 27088376, PMID 27195774, PMID 28821985, PMID 31940698, PMID 32488672, PMID 32804205, PMID 33113526, PMID 33439748, PMID 33646303, PMID 34117080, PMID 34324880, PMID 34492685, PMID 34845352, PMID 35338252, PMID 35725917, PMID 35853728, PMID 36580332, PMID 37561461, PMID 37790304, PMID 37926336, PMID 38195921, PMID 38195922, PMID 39390245, PMID 41214292, PMID 41222934, PMID 42012687

NIH funding

U10CA021115 (2), 2009 (1), U01NS077953 (1), U10CA027469 (1), U10CA180820 (1), U24CA196172 (1)